Lindsey Claire Epperson

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 4

Top Topics

Drug Administration

Cross Sectional

Replacement Therapy

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Jonathan Schimmel, Lindsey Claire Epperson, Kim Aldy, Paul Wax, Jeffrey Brent, Jennie A Buchanan, Michael D Levine, Keith Burkhart, null null
Remdesivir Discontinuation Decisions Based on Thresholds of Aminotransferase in an Observational Registry. Drugs (2024)
Jonathan Schimmel, Lindsey Claire Epperson, Kim Aldy, Paul Wax, Jeffrey Brent, Jennie A Buchanan, Michael D Levine, Keith Burkhart, null null
Remdesivir Discontinuation Decisions Based on Thresholds of Aminotransferase in an Observational Registry. Drugs (2024)
Jonathan Schimmel, Lindsey Claire Epperson, Kim Aldy, Paul Wax, Jeffrey Brent, Jennie A Buchanan, Michael D Levine, Keith Burkhart, null null
Remdesivir Discontinuation Decisions Based on Thresholds of Aminotransferase in an Observational Registry. Drugs 84 (2) (2024)
Jonathan Schimmel, Lindsey Claire Epperson, Kim Aldy, Paul Wax, Jeffrey Brent, Jennie A Buchanan, Michael D Levine, Keith Burkhart, null null
Remdesivir Discontinuation Decisions Based on Thresholds of Aminotransferase in an Observational Registry. Drugs 84 (2) (2024)